07:45 AM EST, 02/20/2025 (MT Newswires) -- Telix Pharmaceuticals ( TLX ) reported 2024 revenue Thursday of 783.2 million Australian dollars ($499.0 million), up from AU$502.5 million a year earlier.

Analysts polled by FactSet expected AU$774.8 million.

The biopharmaceutical firm said it expects 2025 revenue of AU$1.18 billion to AU$1.23 billion.

Analysts surveyed by FactSet expect AU$1.09 billion.

Shares of the company were down more than 2% in recent premarket activity Thursday.

Price: 16.82, Change: -0.37, Percent Change: -2.2